Brief: Celldex Announces Planned Transition Of Chief Financial Officer
15/07/2026 22:02
BRIEF-Celldex Announces Planned Transition Of Chief Financial Officer July 15 (Reuters) - Celldex Therapeutics Inc CLDX.O:
CELLDEX ANNOUNCES PLANNED TRANSITION OF CHIEF FINANCIAL OFFICER
CELLDEX THERAPEUTICS - CELLDX CFO SAM MARTIN PLANS TO RETIRE IN 2027
CELLDEX THERAPEUTICS - CELLDX BEGINS SEARCH FOR NEW CFO; SAM MARTIN TO REMAIN THROUGH MARCH 2027
Source text: ID:nGNX5KbM5P
Further company coverage: CLDX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Celldex Therapeutics
See all newsUS RESEARCH ROUNDUP- Allstate, Autozone, Vertex Pharmaceuticals
U.S. STOCKS ON THE MOVE-Greenland Mines, GameStop, Shopify
Celldex shares slip as safety concerns cloud skin drug trial win (updated)
Celldex falls after two probable anaphylaxis cases in trials
Celldex's skin disease drug meets goals in two late-stage trials